InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by OConnell Daniel Joseph, Chairman & CEO. Officer active across 1 company, notably Acumen Pharmaceuticals, Inc.. Cumulatively, 12 disclosures have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €188k. Activity tracked since 30 November 2021. The latest transaction was filed on 21 January 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to OConnell Daniel Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
9,346 shares@ US$1.81127.5% of flowCommon StockSEC:0001628280-26-003346:0
299,800 shares0Common StockSEC:0001628280-26-002962:0
8,143 shares@ US$1.81946.6% of flowCommon StockSEC:0001628280-26-001895:0
4,649 shares@ US$1.9714.1% of flowCommon StockSEC:0001628280-26-001263:0
12,619 shares@ US$1.59311.9% of flowCommon StockSEC:0001576885-25-000035:0
47,778 shares@ US$1.839252.8% of flowCommon StockSEC:0001576885-25-000021:0
225,400 shares0Common StockSEC:0001576885-25-000021:1
15,200 shares@ US$3.470629.9% of flowCommon StockSEC:0001576885-24-000029:0
401,000 shares0Common StockSEC:0001576885-24-000009:0
114,000 shares0Common StockSEC:0001209191-23-003741:0
1,118 shares@ US$4.472.3% of flowCommon StockSEC:0001209191-21-067613:0
123 sharesCommon StockSEC:0001209191-21-046029:0
12 of 12 declarations
About OConnell Daniel Joseph
OConnell Daniel Joseph is Président-Directeur Général and Chief Executive Officer at Acumen Pharmaceuticals, Inc. The record shows 12 filings in total, and across the 12 sampled filings between 2021-07-08 and 2026-01-23, the modal transaction nature is sale, with total sales of EUR 188309 and no purchases reported.
